gg2
Eye drops recalled over sterility
Archived — this story has rotated out of today’s deck. It is kept here in full.
The gist
Prestige Brands recalled 39,060 Clear Eyes bottles over sterility concerns.
The FDA classified it as Class II, meaning moderate risk of temporary harm.
Background
The recall was initiated due to a 'lack of assurance of sterility' for Clear Eyes Maximum Itchy Eye Relief drops. Sterility is critical for eye products because they can introduce contaminants directly to the eye, bypassing natural defenses. The FDA classified this as a Class II recall, indicating moderate risk. This recall is part of a series of recent eye drop recalls over similar concerns.
How it unfolded
- Jul 29, 2026Prestige Consumer Healthcare initiated the recall voluntarily.
- Aug 20, 2026FDA published the enforcement report, and news outlets reported the recall.
- Aug 22, 2026The Guardian reported the FDA classified it as Class II.
Who’s saying what
- FDA
- The recall is due to potential contamination and lack of assurance of sterility, posing a moderate risk.
- Consumer
- Consumers are advised to stop using the drops and return them for a refund.